patients from a Neuro Ophthalmology who have dry eye, some of which have neurotrophic keratitis are being analyzed after treatment with Vevye
Age18 yr or older Diagnosis of neuro-ophthalmic condition Clinical diagnosis of dry eye disease OSDI score of 23 or greater at baseline Objective sign present Indicated for VEVYE prior to enrollment Ability and willingness to complete study visits and questionnaires
Patients with a corneal ulcer Use of another cyclosporine or lifitegrast product within 30 days of baseline Ocular surgery within 30 prior to baseline Active ocular infection or severe ocular surface condition unrelated to DED Contact lens wearers ( must be off contacts for 30 days and the duration of trial) Any condition that prevents compliance or informed consent Subjects with severe scarring / zero sensitivity
Dry Eye Disease in a Neuro Ophthalmology clinic
Cohort
Prospective
Cyclosporine ophthalmic solution 0.1%
Other interventionone drop in both eyes twice a day
Corneal fluorescein staining
pre vs post treatment
Click on the lead sponsor to view all of their trials.
Neuro-Ophthalmology of Texas
Lead sponsor
Harrow Inc
Collaborator
